Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes
Michael J. Haller(University of Florida), W. J. Russell(Vanderbilt University), Åke Lernmark(Lund University), Antoinette Moran(University of Minnesota), Philip Raskin(Tufts University), Carla J. Greenbaum(Society of Interventional Radiology), Kevan C. Herold(Yale University), María J. Redondo(Baylor College of Medicine), Mark A. Clements(Children's Mercy Hospital), J. Krischer(University of South Florida), Jennifer B. Marks(University of Miami), Jan C. Buckner(McGill University), Andrew J. Muir(Duke University), Desmond Schatz(University of Florida), Linda A. DiMeglio(Urology of Indiana), Peter G. Colman(The Royal Melbourne Hospital), Emanuele Bosi(University of Miami), Dorothy Becker(University of Pittsburgh), Mark A. Atkinson(University of Florida), David A. Baidal(University of Miami), Carmella Evans‐Molina(Richard L. Roudebush VA Medical Center), M. Battaglia(FHNW University of Applied Sciences and Arts Northwestern Switzerland), Mark Peakman(Sanofi (France)), Louis H. Philipson(University of Chicago), Brian N. Bundy(Memorial Sloan Kettering Cancer Center), Darrell M. Wilson(Stanford Medicine), Robin Goland(Columbia University), Henry Rodriguez(Cancer Clinic), Peter A. Gottlieb(University of Colorado Health), Jeffrey P. Krischer(University of South Florida), J. Palmer(Benaroya Research Institute), Stephen E. Gitelman(University of California, San Francisco), Jessica Miller(Advocate Lutheran General Hospital), Dorothy J. Becker(University of Pittsburgh), P. J. Bingley(Benaroya Research Institute), W. Moore(University of Minnesota), Mikael Knip(Åbo Akademi University), Henry Rodriguez(University of South Florida), William E. Russell(Vanderbilt University)
Cited by 183
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
Type 1 diabetes
|The Lancet|2013|2.7k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
An Essential Role for Ectodomain Shedding in Mammalian Development
|Science|1998|1.6k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k